Log In Get Started
Press Releases April 29, 2026 04:07 PM

Brink’s Declares Quarterly Dividend

The Brink's Company announces quarterly dividend payable June 1, 2026.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
BCO

The Brink's Company declared a regular quarterly dividend of $0.255 per share on its common stock, payable on June 1, 2026, to shareholders of record as of May 18, 2026. The company is a global provider of cash and valuables management and related services.

Brink’s Declares Quarterly Dividend
BCO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Brink's declared a quarterly dividend of $0.255 per share.
  • Dividend payment date is June 1, 2026, with record date May 18, 2026.
  • Brink's operates globally, providing cash management, digital retail solutions, and ATM managed services across multiple sectors including financial institutions and retailers.

RICHMOND, Va., April 29, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Brink’s Company (NYSE:BCO) today declared a regular quarterly dividend of $0.255 per share on the Company’s common stock. The dividend is payable on June 1, 2026, to shareholders of record as of May 18, 2026.

About The Brink’s Company
The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services. Our customers include financial institutions, retailers, government agencies, mints, jewelers and other commercial operations. Our network of operations in 51 countries serves customers in more than 100 countries. For more information, please visit our website at www.brinks.com or call 804-289-9709.

Contact:
Investor Relations
804.289.9709


Risks

  • Dividend payments depend on the company’s future financial performance and cash flow, which may be affected by economic conditions impacting financial services and retail sectors.
  • Global operational risks from serving customers in over 100 countries, including geopolitical and regulatory uncertainties.
  • Potential impacts from disruptions in cash handling and digital retail services due to technological changes or security concerns.

More from Press Releases

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026